Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

Completed · Phase 3 · Has a placebo group

Conditions studied: Plantar Fibromatosis, Ledderhose Disease

In brief

This study will assess the efficacy, safety, and tolerability of EN3835 compared to placebo in the treatment of PFI (also known as Ledderhose disease).

Key facts

Study ID
NCT06151197
Run by
Endo USA Inc., a Keenova Therapeutics Company
People needed
436
Starts
2023-11-28
Expected to finish
2026-06-09
Last updated by the study team
2026-07-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.